Insights into Company Bills & Payments

West Pharmaceutical Services Inc.

Medical/Dental Instruments company

📍 United States NYSE WST Pharmaceuticals & Healthcare
Search companies

Key Metrics of West Pharmaceutical Services Inc.

Revenue₹23,863 Cr▲ 13.3% YoYFY 2022-23
EBITDA₹7,064 Cr▲ 8.6% YoY
Net profit₹4,843 Cr▼ 1.6% YoY
Net worth₹22,193 Cr▲ 27.8% YoY
Market cap$29.3BWST · $416.67
Competitors10identified

About West Pharmaceutical Services Inc.

Sectors

Pharmaceuticals & HealthcareFormulations & Contract Manufacturing

Company details

Listed
NYSE: WST

Operational Areas of West Pharmaceutical Services Inc.

Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing

Company summary

Legal nameWest Pharmaceutical Services Inc.
TickerWST
ExchangeNYSE
CountryUnited States
SEC CIK0000105770
Listed since—
IndustryMedical/Dental Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—

US market & SEC filings

WST · NYSE  ·  SEC CIK 0000105770

Last price · 30 Oct 2026 $416.67 +3.23%
Market cap$29.3B
P/E52.9On FY 2023 diluted EPS
Volume1,873,866
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited States

WST share price

Premium

Annual results (SEC EDGAR)

Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.

Sign in to continue See plans & pricing
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Consolidated accounts · FY 2022-23

Indicative long-term—
Indicative short-term—
Score—
LiquidityStrong
DirectionStable

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Information on file33% · missing: Audited financial statements (last 18 months), Capex / investment plans, Lender details, Auditor details, Shareholding pattern, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Registered office and contact

Registered office—
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of West Pharmaceutical Services Inc.

Competitors10identified
Countries1most in United States

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Eli Lilly and Company Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare lilly.com — United States
Johnson & Johnson Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare jjmt.com.tw — United States
Procter & Gamble Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare pg.com — United States
Merck & Co. Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare merck.com — United States
Amgen Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare amgen.com 1983 United States
Gilead Sciences Part of Gilead Sciences. gilead.com 1992 United States
Abbott Laboratories Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare abbott.com — United States
Pfizer Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare pfizer.com — United States
Bristol-Myers Squibb Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare bms.com — United States
Marriott International Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare marriott.com.cn — United States

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.